Stress Management and Resiliency Training (SMART) Integrated Into Treatment of Major Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-29

Study Completion Date

2018-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are doing this research study to find out if the Stress Management and Resiliency Training (SMART) therapy will help subjects with their major depression treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stress Management and Resiliency Training for Depression vs Treatment as Usual in the Treatment of Major Depression

NCT04388748

Major Depression

COMPLETED NA

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

NCT05962879

Anxiety Disorders Psychotic Disorders Depressive Disorder +1 more

RECRUITING NA

The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens

NCT03270943

Depression Mild Resilience, Psychological Adolescent Behavior

COMPLETED NA

Using SMART Experimental Design to Personalize Treatment for Child Depression

NCT01880814

Depression

COMPLETED NA

Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients

NCT00998959

Major Depressive Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators propose to conduct an initial feasibility study in a sample of patients in treatment for major depression using SMART. The intervention will be weekly group therapy session of SMART for 8 weeks duration. Once enrolled, participants will complete a Structured Clinical Interview for Diagnosis (SCID). The SCID will primarily serve to confirm a diagnosis of Major Depressive Disorder. Each study intervention group (3-4 groups) will be composed of 6-8 research participants per group. There will be no comparison group. The investigators aim to assess adherence with goal of 75% completion of the 8 sessions of SMART and of the homework assignments. Resilience will be measured with the Connor-Davidson resilience scale. Secondary outcomes will include subjective and objective clinical rating scales for major depression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Depressed Subjects

Subjects will undergo an 8 week behavioral program with Stress Management and Resiliency Training.

Group Type EXPERIMENTAL

Stress Management and Resiliency Training

Intervention Type BEHAVIORAL

Subjects will undergo an 8 week behavioral program. Treatment will consist of weekly group therapy sessions in small groups with core practices to apply the principles of SMART.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress Management and Resiliency Training

Subjects will undergo an 8 week behavioral program. Treatment will consist of weekly group therapy sessions in small groups with core practices to apply the principles of SMART.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SMART

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Attending the Mayo Clinic Depression Center and Behavioral Health Clinic at Mayo Clinic Health System, Austin, Minnesota
* DSM-V diagnostic confirmation of major depressive disorder (MDD)
* Baseline PHQ-9 scores in the range of ≥6-≤19, and HAMD-17 score 8-18, or QIDS-C16 score of 6-20
* Able to speak English
* Participants will continue taking any prescribed medications from their clinical treatment team
* Patients with co-morbid secondary diagnoses of persistent depressive disorder and generalized anxiety disorders will be included in the study.

Exclusion Criteria

* Participants with bipolar disorder
* Active psychosis
* Active suicidal ideations
* Active substance abuse meeting criteria for substance use disorders except nicotine
* Obsessive compulsive disorder
* Active Panic disorder with agoraphobia, other phobic disorder
* Active Posttraumatic stress disorder
* Active Severe personality disorders.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No